A randomised open-label trial comparing long-term sub-cutaneous low-molecular-weight heparin compared with oral-anticoagulant therapy in the treatment of deep venous thrombosis.
about
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancerVitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolismAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVenous thromboembolism in cancer patients: an underestimated major health problemVenous thromboembolism in patients with hematologic malignancy and thrombocytopenia.CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.Treatment of thromboembolism in cancer patients.Initial and long-term treatment of deep venous thrombosis: recent clinical trials and their impact on patient management.Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials.Safety of anticoagulant treatment in cancer patients.Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer.Venous Thromboembolism in Patients Diagnosed With Lung Cancer.Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.Long-term treatment of cancer-associated thrombosis: the choice of the optimal anticoagulant.Treatment for patients with cancer.Diagnosis and anticoagulant treatment.Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options.
P2860
Q24194904-FBD5FDDA-69F9-4F3F-829A-D441ED7B1426Q24198032-CA4BB485-9C91-45B6-89BD-3A9611F40C75Q24633053-E51E742A-7A39-438D-92BD-6BBB66E0048CQ26852015-248A6853-C8B1-4553-9B93-93D9B39BAA83Q33434346-1A9882D2-868C-43D6-BB7A-369B54DE46DCQ34771524-4B997406-66BB-41E7-8BAC-8D2BE58AA1E6Q37190522-9CAEE61D-8058-47A1-91CC-781393A23AE0Q37773994-CFA6858A-E4C8-49AF-AF6E-FEB14A24FF5AQ38081938-A73355A6-858B-41F0-9D8C-C6DB0CB2AC39Q38395008-27D35F61-05E7-468D-A33C-0C2A4B315423Q38523012-BE20390C-D6B3-468F-ABE2-64DD8D57ED3FQ38600392-10EE9E12-3F4F-4534-91D2-141D74D7C9C4Q38664988-C828A163-1BE9-49D8-9D39-FDEEB6D4383EQ38686333-468D4EA7-BEA3-4F0C-9773-CD6417541EDDQ38910847-3764784D-48F1-456F-9F45-CC37D329C92FQ38944457-E36F3D2E-5082-4F81-9C15-4565AFF10E10Q38962411-BBB2F117-29DB-4F32-B2C3-AD715EB44A2FQ39145374-D7C9DD9F-CBC5-427C-BAB4-7EBD8B4B573CQ44188629-4D42BB7D-FEDB-4C6E-A382-DCDD49DCE8FFQ45847579-8CC2453B-7B14-4ECF-A658-C4CA4A28959CQ48015257-D14CDCF0-9084-4F90-BEF2-B433DCC0E815Q55364590-F8ED7985-B540-472A-8FCE-F2DEAA033CF7
P2860
A randomised open-label trial comparing long-term sub-cutaneous low-molecular-weight heparin compared with oral-anticoagulant therapy in the treatment of deep venous thrombosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A randomised open-label trial ...... ent of deep venous thrombosis.
@en
A randomised open-label trial ...... ent of deep venous thrombosis.
@nl
type
label
A randomised open-label trial ...... ent of deep venous thrombosis.
@en
A randomised open-label trial ...... ent of deep venous thrombosis.
@nl
prefLabel
A randomised open-label trial ...... ent of deep venous thrombosis.
@en
A randomised open-label trial ...... ent of deep venous thrombosis.
@nl
P2093
P1476
A randomised open-label trial ...... ent of deep venous thrombosis.
@en
P2093
M A Cairols
O Lapiedra
R Vila-Coll
P304
P356
10.1016/J.EJVS.2008.11.030
P577
2009-01-01T00:00:00Z